Suppliers / Antibioticos Do Brasil Ltda

Antibioticos Do Brasil Ltda

Mexico 39 employees Updated 9 July 2026

Antibioticos Do Brasil Ltda is an API and finished-dose manufacturer based in Mexico. It holds 5 active US drug master files and one valid CEP across a filed portfolio of 7 molecules. Its filings concentrate with ANVISA (Brazil), COFEPRIS (MX) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), EMA and COFEPRIS (MX), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 27 May 2022 as NAI.

5
active US DMFs
1
valid CEPs
8
registered plants 1 with an FDA FEI number
166
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 27 May 2022 NAI US FDA
  • 28 August 2018 OAI US FDA
  • 27 April 2016 OAI US FDA
  • 26 February 2013 VAI US FDA
  • 18 March 2010 VAI US FDA
  • 6 November 2008 OAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
COSMOPOLIS, Brazil Not on file
Brazil, Brazil 3004132818
SUMARÉ, Brazil Not on file
Cosmopolis Sao Paulo, Brasil, Colombia Not on file
Coyoacán, Mexico Not on file
Texcoco, Mexico Not on file

2 further sites are on record.

What they file, and where

Molecule Regulators Docs
Cefepime SFDA (Saudi Arabia), US FDA 2
Amoxicillin US FDA 1
Ampicillin US FDA 1
Arginine US FDA 1
Ceftazidime Pentahydrate With Sodium Carbonate For Injection EDQM 1
Ceftobiprole Medocaril Sodium SFDA (Saudi Arabia) 1
Cephalexin US FDA 1

Also appears on these molecule pages

Show 2 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ANVISA (Brazil) 137 6
COFEPRIS (MX) 9 2
ARCSA (EC) 8 None
INVIMA (CO) 7 1
DIGEMAPS (DO) 5 None
EMA None 4

Comparing suppliers?

Choose your molecules and target markets. Antibioticos Do Brasil Ltda comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was NAI, on 27 May 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates